Wall Street analysts continue to closely monitor the drama playing out among the major health carriers.
The possibility that an acquisition was imminent by Aetna of either Cigna or Humana was floated Monday after an investors' meeting hosted by Ana Gupte of Leerink Partners at Aetna headquarters. She speculated that Aetna would find either of those carriers attractive targets due to their Medicare business, a segment where Aetna has a gaping hole.
The stocks of all three bounced up and down Tuesday and Wednesday on the speculation. Shares of all three closed higher on Thursday, with Aetna experiencing the highest uptick — 1.54 percent.
Recommended For You
Speculation focused on Humana as the most likely target. But analysts say Aetna would have to be ready to pay about $200 a share — nearly $30 above the closing price Thursday of $174.25.
But with the insurance industry being propelled higher on Wall Street by the increased business from the Patient Protection and Affordable Care Act, that price could look like a bargain in six months.
"Despite fluctuations in its stock price, Humana's legacy makes it an attractive acquisition target," said FierceHealthPlayer analyst Dori Zweig, referring to its booming Medicare business.
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.